# Abvc Biopharma, Inc.: filings

ABVC · Nasdaq · CIK 1173313 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abvc.md) · [Financials](/companies/abvc/financials.md) · [Filings](/companies/abvc/filings.md) · [Insiders](/companies/abvc/insiders.md)

## Reports and events: 428 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 217, 10-Q 53, 8-K/A 39, 424B4 38, 4 29, S-1/A 29, CORRESP 24, UPLOAD 22, 10-Q/A 19, SC 13D 19, 3 18, 10-K 17, EFFECT 16, NT 10-Q 15, 10-K/A 14, POS AM 14, 424B3 11, NT 10-K 9, DEF 14A 8, S-1 8, PRE 14A 7, SC 13G 7, 4/A 5, 424B5 4, RW 4, S-8 4, 5 3, AW 3, D 3, PRER14A 3, S-4/A 3, SC 13D/A 3, DEFA14A 2, S-3 2, SC 13G/A 2, SCHEDULE 13G/A 2, 10-KT 1, 424B2 1, 8-A12B 1, CERT 1, PREM14A 1, S-1MEF 1, S-3/A 1, S-4 1, S-8 POS 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 12:22 ET | [DEF 14A](/filings/0001213900-26-104509.md) | Proxy statement, period 2026-10-28 | 0001213900-26-104509 |
| 2026-08-27 | 08:30 ET | [8-K](/filings/0001213900-26-094152.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-094152 |
| 2026-08-12 | 16:06 ET | [10-Q](/filings/0001213900-26-088348.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088348 |
| 2026-08-12 | 11:50 ET | [8-K/A](/filings/0001213900-26-088165.md) | 8.01 Other events | 0001213900-26-088165 |
| 2026-08-04 | 21:12 ET | [8-K](/filings/0001213900-26-084846.md) | 8.01 Other events | 0001213900-26-084846 |
| 2026-07-02 | 16:01 ET | [8-K](/filings/0001213900-26-074949.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-074949 |
| 2026-05-18 | 07:22 ET | [10-Q](/filings/0001213900-26-058104.md) | Quarterly report, period 2026-03-31 | 0001213900-26-058104 |
| 2026-03-27 | 16:05 ET | [8-K](/filings/0001213900-26-035499.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-035499 |
| 2026-03-05 | 16:29 ET | [DEF 14A](/filings/0001213900-26-024122.md) | Proxy statement, period 2026-03-26 | 0001213900-26-024122 |
| 2026-03-03 | 16:20 ET | [10-K](/filings/0001213900-26-023063.md) | Annual report, period 2025-12-31 | 0001213900-26-023063 |
| 2026-03-03 | 16:19 ET | [10-Q/A](/filings/0001213900-26-023062.md) | Quarterly report, amended, period 2025-09-30 | 0001213900-26-023062 |
| 2026-03-03 | 16:14 ET | [8-K](/filings/0001213900-26-023054.md) | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001213900-26-023054 |
| 2026-01-16 | 16:30 ET | [8-K/A](/filings/0001213900-26-005165.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-005165 |
| 2025-11-03 | 07:30 ET | [8-K](/filings/0001213900-25-104900.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-104900 |
| 2025-11-03 | 19:39 ET | [10-Q](/filings/0001213900-25-104811.md) | Quarterly report, period 2025-09-30 | 0001213900-25-104811 |
| 2025-10-30 | 08:31 ET | [8-K](/filings/0001213900-25-103799.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-103799 |
| 2025-09-12 | 19:16 ET | [8-K/A](/filings/0001213900-25-086952.md) | 4.01 Change of auditor | 0001213900-25-086952 |
| 2025-08-14 | 07:02 ET | [8-K](/filings/0001213900-25-076018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076018 |
| 2025-08-13 | 16:02 ET | [10-Q](/filings/0001213900-25-075644.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075644 |
| 2025-07-18 | 17:04 ET | [8-K/A](/filings/0001213900-25-065728.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-065728 |
| 2025-07-15 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001213900-25-064283.md) | Ownership report, active investor, amended | 0001213900-25-064283 |
| 2025-06-04 | 16:01 ET | [8-K](/filings/0001213900-25-051144.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-051144 |
| 2025-06-03 | 16:01 ET | [SCHEDULE 13D](/filings/0001213900-25-050762.md) | Ownership report, active investor | 0001213900-25-050762 |
| 2025-05-30 | 16:30 ET | [8-K/A](/filings/0001213900-25-049491.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-049491 |
| 2025-05-16 | 16:30 ET | [DEF 14A](/filings/0001213900-25-044910.md) | Proxy statement, period 2025-06-03 | 0001213900-25-044910 |
| 2025-05-14 | 16:30 ET | [8-K/A](/filings/0001213900-25-043354.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-043354 |
| 2025-05-14 | 08:30 ET | [8-K/A](/filings/0001213900-25-042982.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042982 |
| 2025-05-06 | 16:30 ET | [8-K/A](/filings/0001213900-25-040194.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-040194 |
| 2025-05-02 | 16:30 ET | [8-K/A](/filings/0001213900-25-039184.md) | 4.02 Non-reliance on financial statements | 0001213900-25-039184 |
| 2025-05-01 | 08:00 ET | [8-K](/filings/0001213900-25-038060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-038060 |
| 2025-04-30 | 16:41 ET | [10-Q](/filings/0001213900-25-037676.md) | Quarterly report, period 2025-03-31 | 0001213900-25-037676 |
| 2025-04-30 | 16:30 ET | [8-K](/filings/0001213900-25-037654.md) | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-037654 |
| 2025-04-16 | 13:42 ET | [8-K/A](/filings/0001213900-25-032468.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-032468 |
| 2025-04-15 | 16:30 ET | [8-K](/filings/0001213900-25-032135.md) | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-032135 |
| 2025-04-15 | 16:23 ET | [10-K](/filings/0001213900-25-032118.md) | Annual report, period 2024-12-31 | 0001213900-25-032118 |
| 2025-03-07 | 16:01 ET | [8-K](/filings/0001213900-25-021713.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-021713 |
| 2025-01-13 | 18:56 ET | [8-K/A](/filings/0001213900-25-002769.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-002769 |
| 2025-01-06 | 17:00 ET | [8-K](/filings/0001213900-25-001211.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-001211 |
| 2024-11-14 | 09:25 ET | [8-K](/filings/0001213900-24-097894.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-097894 |
| 2024-11-14 | 08:30 ET | [10-Q](/filings/0001213900-24-097840.md) | Quarterly report, period 2024-09-30 | 0001213900-24-097840 |
| 2024-11-04 | 17:00 ET | [8-K](/filings/0001213900-24-094178.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-094178 |
| 2024-10-18 | 17:23 ET | [8-K](/filings/0001213900-24-089013.md) | 4.01 Change of auditor | 0001213900-24-089013 |
| 2024-09-10 | 16:01 ET | [8-K](/filings/0001213900-24-077361.md) | 8.01 Other events | 0001213900-24-077361 |
| 2024-08-20 | 16:30 ET | [8-K](/filings/0001213900-24-071145.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-071145 |
| 2024-08-15 | 07:00 ET | [8-K](/filings/0001213900-24-069338.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-069338 |
| 2024-08-14 | 15:18 ET | [10-Q](/filings/0001213900-24-068907.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068907 |
| 2024-07-23 | 17:00 ET | [8-K](/filings/0001213900-24-063627.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001213900-24-063627 |
| 2024-07-12 | 16:05 ET | [8-K](/filings/0001213900-24-061028.md) | 3.01 Delisting notice | 0001213900-24-061028 |
| 2024-06-25 | 17:15 ET | [8-K/A](/filings/0001213900-24-055809.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-055809 |
| 2024-06-24 | 17:15 ET | [8-K/A](/filings/0001213900-24-055288.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-055288 |

Page 1 of 9. [Older](/companies/abvc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.